Post-Marketing Surveillance of Vliwazell® Prowound Dressing
ConditionAcute and Chronic Wounds
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLohmann & Rauscher
About this trial
This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell® Pro. The aim of the study is to validate the performance of Vliwazell® Pro within its intended purpose and certified indications during routine use, and to gather additional safety data. The study will examine how the use of the dressing affects the condition of the skin surrounding the wound, the wound status in terms of exudate, wound odor, and other parameters. Furthermore, the satisfaction of healthcare providers and patients with the application of the dressing will be assessed.
Eligibility criteria
Qualifiers
arterial and venous ulcers
diabetic ulcers
pressure ulcers
post-traumatic wounds
Disqualifiers
Age < 18 years
Known allergy and/or hypersensitivity to any of the product components.
Not for use in tunnel-forming wound pockets, as the product may expand considerably with the absorption of wound exudate.
Not for use on dry wounds.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov